[1]
2022. Outcomes of dutasteride discontinuation in patients with benign prostatic hypertrophy. Archivio Italiano di Urologia e Andrologia. 94, 4 (Dec. 2022), 521–524. DOI:https://doi.org/10.4081/aiua.2022.4.521.